By expenditures
| Name | Title | Type |
|---|---|---|
| Charisse Wilson | Chief Business Officer | Auditee |
| Darrin Davis | CHIEF BUSINESS OFFICIAL | Auditee |
| Andrew Park | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 357316 | 2024 | 2025-05-28 | Eide Bailly LLP | $4.65M |
| 328293 | 2023 | 2024-11-13 | Eide Bailly LLP | $4.85M |
| 34872 | 2022 | 2023-04-20 | Eide Bailly LLP | $3.78M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 357316 | 2024 | 2025-05-28 | 1138136 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 1138135 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 1138134 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 1138133 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 1138132 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 1138131 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 1138130 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 1138129 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 1138128 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 1138127 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 561694 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 561693 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 561692 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 561691 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 561690 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 561689 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 561688 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 561687 | 2024-003 | Material Weakness | Yes | L |
| 357316 | 2024 | 2025-05-28 | 561686 | 2024-004 | Material Weakness | Yes | F |
| 357316 | 2024 | 2025-05-28 | 561685 | 2024-003 | Material Weakness | Yes | L |
| 328293 | 2023 | 2024-11-13 | 1084246 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084245 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084244 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084243 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084242 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084241 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 1084240 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 1084239 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 1084238 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 1084237 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 1084236 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 1084235 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507804 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507803 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507802 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507801 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507800 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507799 | 2023-003 | Significant Deficiency | - | A |
| 328293 | 2023 | 2024-11-13 | 507798 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507797 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507796 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507795 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507794 | 2023-002 | Significant Deficiency | - | L |
| 328293 | 2023 | 2024-11-13 | 507793 | 2023-002 | Significant Deficiency | - | L |